Tri-Med 180mg/ml as a Nutritional-Phase Anchor in Trenbolone Cycling
Tri-Med by Bioniche Pharma is a three-ester Trenbolone injectable whose sustained androgenic output makes it a practical tool for athletes managing caloric strategy across bulk, cut, and body recomposition phases. Unlike single-ester formulations that demand precise timing to prevent plasma troughs during dietary transitions, the staggered release profile of Tri-Med maintains androgenic continuity whether the user is in a caloric surplus, a deficit, or at maintenance. Trenbolone's glucocorticoid receptor antagonism reduces cortisol-driven protein catabolism, a mechanism confirmed in receptor-binding studies, which means dietary protein is directed toward muscle protein synthesis rather than energy metabolism under deficit conditions.
Caloric Targets and Macronutrient Priorities on Cycle
Caloric needs shift meaningfully during a Trenbolone cycle. Users in a recomposition phase typically operate within ±200 kcal of their Total Daily Energy Expenditure (TDEE), relying on the compound's nitrogen-retention capacity — measured via urinary nitrogen balance studies — to preserve lean tissue while body fat decreases. Compared to a standard caloric deficit without androgenic support, cycle-supported deficits allow a steeper negative energy balance without proportional lean mass loss. Protein intake recommendations from sports nutrition literature place the optimal range at 2.2–3.1 g per kg of bodyweight daily during anabolic cycles, a figure that rises toward the upper boundary as caloric restriction deepens.
Micronutrient and Dietary Fat Considerations
Trenbolone suppresses endogenous testosterone production, which in turn affects dietary fat requirements: cholesterol-bearing fats from whole eggs, red meat, and oily fish support the residual endogenous steroidogenic pathway and assist in maintaining HDL cholesterol under the compound's lipid-altering pressure. Bioniche Pharma's production framework for Tri-Med requires the finished 10ml vial — as sealed and labelled — to pass HPLC concentration verification and LAL endotoxin clearance before distribution, ensuring dose accuracy that nutrition-period planning depends on. Each 0.5ml draw at 180mg/ml delivers exactly 90mg of Trenbolone complex, a fixed unit that keeps per-injection dose arithmetic stable when weekly caloric totals are being adjusted simultaneously.
Recomp Efficiency and Dietary Timing
Carbohydrate timing around resistance training sessions amplifies the compound's nutrient-partitioning characteristics: placing the majority of daily carbohydrate intake in the pre- and post-training windows, as supported by glycogen-resynthesis kinetics literature, aligns dietary glucose availability with peak muscular demand. Tri-Med's Acetate fraction establishes early androgenic activity that supports training intensity from the first week, while the Enanthate and Hexahydrobenzylcarbonate fractions extend anabolic signalling across the full dietary cycle without requiring compound switches. Dietary fibre targets of 25–38 g daily, consistent with established gastrointestinal health guidelines, remain important given that Trenbolone can affect gut motility in sensitive users.